Global Personalized Medicine (PM) Solution Market 2022 by Company, Regions, Type and Application, Forecast to 2028
The Personalized Medicine (PM) Solution market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Personalized Medicine (PM) Solution market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Oncology accounting for % of the Personalized Medicine (PM) Solution global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Personalized Diagnostics segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Personalized Medicine (PM) Solution include 2bPrecise, OneOme, TIGAR Health- IR2Dx, Kailos Genetics, and Syapse Inc, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Personalized Medicine (PM) Solution market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chapter 1, to describe Personalized Medicine (PM) Solution product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Personalized Medicine (PM) Solution, with revenue, gross margin and global market share of Personalized Medicine (PM) Solution from 2019 to 2022.
Chapter 3, the Personalized Medicine (PM) Solution competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Personalized Medicine (PM) Solution market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Personalized Medicine (PM) Solution research findings and conclusion, appendix and data source.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Personalized Medicine (PM) Solution market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Oncology accounting for % of the Personalized Medicine (PM) Solution global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Personalized Diagnostics segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Personalized Medicine (PM) Solution include 2bPrecise, OneOme, TIGAR Health- IR2Dx, Kailos Genetics, and Syapse Inc, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Personalized Medicine (PM) Solution market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
- Personalized Diagnostics
- Personalized Therapies
- Personalized Nutrition & Wellness
- Oncology
- Neurosciences
- Immunology
- Respiratory
- Others
- 2bPrecise
- OneOme
- TIGAR Health- IR2Dx
- Kailos Genetics
- Syapse Inc
- Karius
- Astarte Medical
- Fabric Genomics, INC.
- Orion Health
- 2B Precise
- Fabric Genomics
- Pfizer
- Gene 42
- IBM Watson Health
- Philips Healthcare
- Medtronic
- Nanthealth
- Navican
- N-of-One
- PierianDx
- Sunquest Information System
- Tempus
- Novartis
- Translational Software
- Biocrates Life Sciences AG
- Nanostring Technologies
- Thermo Fisher Scientific
- Quest Diagnostics Incorporated
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
- South America (Brazil, Argentina, Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Personalized Medicine (PM) Solution product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Personalized Medicine (PM) Solution, with revenue, gross margin and global market share of Personalized Medicine (PM) Solution from 2019 to 2022.
Chapter 3, the Personalized Medicine (PM) Solution competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Personalized Medicine (PM) Solution market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Personalized Medicine (PM) Solution research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Personalized Medicine (PM) Solution
1.2 Classification of Personalized Medicine (PM) Solution by Type
1.2.1 Overview: Global Personalized Medicine (PM) Solution Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Personalized Medicine (PM) Solution Revenue Market Share by Type in 2021
1.2.3 Personalized Diagnostics
1.2.4 Personalized Therapies
1.2.5 Personalized Nutrition & Wellness
1.3 Global Personalized Medicine (PM) Solution Market by Application
1.3.1 Overview: Global Personalized Medicine (PM) Solution Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Oncology
1.3.3 Neurosciences
1.3.4 Immunology
1.3.5 Respiratory
1.3.6 Others
1.4 Global Personalized Medicine (PM) Solution Market Size & Forecast
1.5 Global Personalized Medicine (PM) Solution Market Size and Forecast by Region
1.5.1 Global Personalized Medicine (PM) Solution Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Personalized Medicine (PM) Solution Market Size by Region, (2017-2022)
1.5.3 North America Personalized Medicine (PM) Solution Market Size and Prospect (2017-2028)
1.5.4 Europe Personalized Medicine (PM) Solution Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Personalized Medicine (PM) Solution Market Size and Prospect (2017-2028)
1.5.6 South America Personalized Medicine (PM) Solution Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Personalized Medicine (PM) Solution Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Personalized Medicine (PM) Solution Market Drivers
1.6.2 Personalized Medicine (PM) Solution Market Restraints
1.6.3 Personalized Medicine (PM) Solution Trends Analysis
2 COMPANY PROFILES
2.1 2bPrecise
2.1.1 2bPrecise Details
2.1.2 2bPrecise Major Business
2.1.3 2bPrecise Personalized Medicine (PM) Solution Product and Solutions
2.1.4 2bPrecise Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 2bPrecise Recent Developments and Future Plans
2.2 OneOme
2.2.1 OneOme Details
2.2.2 OneOme Major Business
2.2.3 OneOme Personalized Medicine (PM) Solution Product and Solutions
2.2.4 OneOme Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 OneOme Recent Developments and Future Plans
2.3 TIGAR Health- IR2Dx
2.3.1 TIGAR Health- IR2Dx Details
2.3.2 TIGAR Health- IR2Dx Major Business
2.3.3 TIGAR Health- IR2Dx Personalized Medicine (PM) Solution Product and Solutions
2.3.4 TIGAR Health- IR2Dx Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 TIGAR Health- IR2Dx Recent Developments and Future Plans
2.4 Kailos Genetics
2.4.1 Kailos Genetics Details
2.4.2 Kailos Genetics Major Business
2.4.3 Kailos Genetics Personalized Medicine (PM) Solution Product and Solutions
2.4.4 Kailos Genetics Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Kailos Genetics Recent Developments and Future Plans
2.5 Syapse Inc
2.5.1 Syapse Inc Details
2.5.2 Syapse Inc Major Business
2.5.3 Syapse Inc Personalized Medicine (PM) Solution Product and Solutions
2.5.4 Syapse Inc Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Syapse Inc Recent Developments and Future Plans
2.6 Karius
2.6.1 Karius Details
2.6.2 Karius Major Business
2.6.3 Karius Personalized Medicine (PM) Solution Product and Solutions
2.6.4 Karius Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Karius Recent Developments and Future Plans
2.7 Astarte Medical
2.7.1 Astarte Medical Details
2.7.2 Astarte Medical Major Business
2.7.3 Astarte Medical Personalized Medicine (PM) Solution Product and Solutions
2.7.4 Astarte Medical Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Astarte Medical Recent Developments and Future Plans
2.8 Fabric Genomics, INC.
2.8.1 Fabric Genomics, INC. Details
2.8.2 Fabric Genomics, INC. Major Business
2.8.3 Fabric Genomics, INC. Personalized Medicine (PM) Solution Product and Solutions
2.8.4 Fabric Genomics, INC. Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Fabric Genomics, INC. Recent Developments and Future Plans
2.9 Orion Health
2.9.1 Orion Health Details
2.9.2 Orion Health Major Business
2.9.3 Orion Health Personalized Medicine (PM) Solution Product and Solutions
2.9.4 Orion Health Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Orion Health Recent Developments and Future Plans
2.10 2B Precise
2.10.1 2B Precise Details
2.10.2 2B Precise Major Business
2.10.3 2B Precise Personalized Medicine (PM) Solution Product and Solutions
2.10.4 2B Precise Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 2B Precise Recent Developments and Future Plans
2.11 Fabric Genomics
2.11.1 Fabric Genomics Details
2.11.2 Fabric Genomics Major Business
2.11.3 Fabric Genomics Personalized Medicine (PM) Solution Product and Solutions
2.11.4 Fabric Genomics Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Fabric Genomics Recent Developments and Future Plans
2.12 Pfizer
2.12.1 Pfizer Details
2.12.2 Pfizer Major Business
2.12.3 Pfizer Personalized Medicine (PM) Solution Product and Solutions
2.12.4 Pfizer Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Pfizer Recent Developments and Future Plans
2.13 Gene
2.13.1 Gene 42 Details
2.13.2 Gene 42 Major Business
2.13.3 Gene 42 Personalized Medicine (PM) Solution Product and Solutions
2.13.4 Gene 42 Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Gene 42 Recent Developments and Future Plans
2.14 IBM Watson Health
2.14.1 IBM Watson Health Details
2.14.2 IBM Watson Health Major Business
2.14.3 IBM Watson Health Personalized Medicine (PM) Solution Product and Solutions
2.14.4 IBM Watson Health Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 IBM Watson Health Recent Developments and Future Plans
2.15 Philips Healthcare
2.15.1 Philips Healthcare Details
2.15.2 Philips Healthcare Major Business
2.15.3 Philips Healthcare Personalized Medicine (PM) Solution Product and Solutions
2.15.4 Philips Healthcare Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Philips Healthcare Recent Developments and Future Plans
2.16 Medtronic
2.16.1 Medtronic Details
2.16.2 Medtronic Major Business
2.16.3 Medtronic Personalized Medicine (PM) Solution Product and Solutions
2.16.4 Medtronic Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 Medtronic Recent Developments and Future Plans
2.17 Nanthealth
2.17.1 Nanthealth Details
2.17.2 Nanthealth Major Business
2.17.3 Nanthealth Personalized Medicine (PM) Solution Product and Solutions
2.17.4 Nanthealth Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17.5 Nanthealth Recent Developments and Future Plans
2.18 Navican
2.18.1 Navican Details
2.18.2 Navican Major Business
2.18.3 Navican Personalized Medicine (PM) Solution Product and Solutions
2.18.4 Navican Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18.5 Navican Recent Developments and Future Plans
2.19 N-of-One
2.19.1 N-of-One Details
2.19.2 N-of-One Major Business
2.19.3 N-of-One Personalized Medicine (PM) Solution Product and Solutions
2.19.4 N-of-One Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19.5 N-of-One Recent Developments and Future Plans
2.20 PierianDx
2.20.1 PierianDx Details
2.20.2 PierianDx Major Business
2.20.3 PierianDx Personalized Medicine (PM) Solution Product and Solutions
2.20.4 PierianDx Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20.5 PierianDx Recent Developments and Future Plans
2.21 Sunquest Information System
2.21.1 Sunquest Information System Details
2.21.2 Sunquest Information System Major Business
2.21.3 Sunquest Information System Personalized Medicine (PM) Solution Product and Solutions
2.21.4 Sunquest Information System Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.21.5 Sunquest Information System Recent Developments and Future Plans
2.22 Tempus
2.22.1 Tempus Details
2.22.2 Tempus Major Business
2.22.3 Tempus Personalized Medicine (PM) Solution Product and Solutions
2.22.4 Tempus Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.22.5 Tempus Recent Developments and Future Plans
2.23 Novartis
2.23.1 Novartis Details
2.23.2 Novartis Major Business
2.23.3 Novartis Personalized Medicine (PM) Solution Product and Solutions
2.23.4 Novartis Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.23.5 Novartis Recent Developments and Future Plans
2.24 Translational Software
2.24.1 Translational Software Details
2.24.2 Translational Software Major Business
2.24.3 Translational Software Personalized Medicine (PM) Solution Product and Solutions
2.24.4 Translational Software Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.24.5 Translational Software Recent Developments and Future Plans
2.25 Biocrates Life Sciences AG
2.25.1 Biocrates Life Sciences AG Details
2.25.2 Biocrates Life Sciences AG Major Business
2.25.3 Biocrates Life Sciences AG Personalized Medicine (PM) Solution Product and Solutions
2.25.4 Biocrates Life Sciences AG Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.25.5 Biocrates Life Sciences AG Recent Developments and Future Plans
2.26 Nanostring Technologies
2.26.1 Nanostring Technologies Details
2.26.2 Nanostring Technologies Major Business
2.26.3 Nanostring Technologies Personalized Medicine (PM) Solution Product and Solutions
2.26.4 Nanostring Technologies Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.26.5 Nanostring Technologies Recent Developments and Future Plans
2.27 Thermo Fisher Scientific
2.27.1 Thermo Fisher Scientific Details
2.27.2 Thermo Fisher Scientific Major Business
2.27.3 Thermo Fisher Scientific Personalized Medicine (PM) Solution Product and Solutions
2.27.4 Thermo Fisher Scientific Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.27.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.28 Quest Diagnostics Incorporated
2.28.1 Quest Diagnostics Incorporated Details
2.28.2 Quest Diagnostics Incorporated Major Business
2.28.3 Quest Diagnostics Incorporated Personalized Medicine (PM) Solution Product and Solutions
2.28.4 Quest Diagnostics Incorporated Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.28.5 Quest Diagnostics Incorporated Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Personalized Medicine (PM) Solution Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Personalized Medicine (PM) Solution Players Market Share in 2021
3.2.2 Top 10 Personalized Medicine (PM) Solution Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Personalized Medicine (PM) Solution Players Head Office, Products and Services Provided
3.4 Personalized Medicine (PM) Solution Mergers & Acquisitions
3.5 Personalized Medicine (PM) Solution New Entrants and Expansion Plans
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Personalized Medicine (PM) Solution Revenue and Market Share by Type (2017-2022)
4.2 Global Personalized Medicine (PM) Solution Market Forecast by Type (2023-2028)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Personalized Medicine (PM) Solution Revenue Market Share by Application (2017-2022)
5.2 Global Personalized Medicine (PM) Solution Market Forecast by Application (2023-2028)
6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
6.1 North America Personalized Medicine (PM) Solution Revenue by Type (2017-2028)
6.2 North America Personalized Medicine (PM) Solution Revenue by Application (2017-2028)
6.3 North America Personalized Medicine (PM) Solution Market Size by Country
6.3.1 North America Personalized Medicine (PM) Solution Revenue by Country (2017-2028)
6.3.2 United States Personalized Medicine (PM) Solution Market Size and Forecast (2017-2028)
6.3.3 Canada Personalized Medicine (PM) Solution Market Size and Forecast (2017-2028)
6.3.4 Mexico Personalized Medicine (PM) Solution Market Size and Forecast (2017-2028)
7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 Europe Personalized Medicine (PM) Solution Revenue by Type (2017-2028)
7.2 Europe Personalized Medicine (PM) Solution Revenue by Application (2017-2028)
7.3 Europe Personalized Medicine (PM) Solution Market Size by Country
7.3.1 Europe Personalized Medicine (PM) Solution Revenue by Country (2017-2028)
7.3.2 Germany Personalized Medicine (PM) Solution Market Size and Forecast (2017-2028)
7.3.3 France Personalized Medicine (PM) Solution Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Personalized Medicine (PM) Solution Market Size and Forecast (2017-2028)
7.3.5 Russia Personalized Medicine (PM) Solution Market Size and Forecast (2017-2028)
7.3.6 Italy Personalized Medicine (PM) Solution Market Size and Forecast (2017-2028)
8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
8.1 Asia-Pacific Personalized Medicine (PM) Solution Revenue by Type (2017-2028)
8.2 Asia-Pacific Personalized Medicine (PM) Solution Revenue by Application (2017-2028)
8.3 Asia-Pacific Personalized Medicine (PM) Solution Market Size by Region
8.3.1 Asia-Pacific Personalized Medicine (PM) Solution Revenue by Region (2017-2028)
8.3.2 China Personalized Medicine (PM) Solution Market Size and Forecast (2017-2028)
8.3.3 Japan Personalized Medicine (PM) Solution Market Size and Forecast (2017-2028)
8.3.4 South Korea Personalized Medicine (PM) Solution Market Size and Forecast (2017-2028)
8.3.5 India Personalized Medicine (PM) Solution Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Personalized Medicine (PM) Solution Market Size and Forecast (2017-2028)
8.3.7 Australia Personalized Medicine (PM) Solution Market Size and Forecast (2017-2028)
9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
9.1 South America Personalized Medicine (PM) Solution Revenue by Type (2017-2028)
9.2 South America Personalized Medicine (PM) Solution Revenue by Application (2017-2028)
9.3 South America Personalized Medicine (PM) Solution Market Size by Country
9.3.1 South America Personalized Medicine (PM) Solution Revenue by Country (2017-2028)
9.3.2 Brazil Personalized Medicine (PM) Solution Market Size and Forecast (2017-2028)
9.3.3 Argentina Personalized Medicine (PM) Solution Market Size and Forecast (2017-2028)
10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
10.1 Middle East & Africa Personalized Medicine (PM) Solution Revenue by Type (2017-2028)
10.2 Middle East & Africa Personalized Medicine (PM) Solution Revenue by Application (2017-2028)
10.3 Middle East & Africa Personalized Medicine (PM) Solution Market Size by Country
10.3.1 Middle East & Africa Personalized Medicine (PM) Solution Revenue by Country (2017-2028)
10.3.2 Turkey Personalized Medicine (PM) Solution Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Personalized Medicine (PM) Solution Market Size and Forecast (2017-2028)
10.3.4 UAE Personalized Medicine (PM) Solution Market Size and Forecast (2017-2028)
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Product Overview and Scope of Personalized Medicine (PM) Solution
1.2 Classification of Personalized Medicine (PM) Solution by Type
1.2.1 Overview: Global Personalized Medicine (PM) Solution Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Personalized Medicine (PM) Solution Revenue Market Share by Type in 2021
1.2.3 Personalized Diagnostics
1.2.4 Personalized Therapies
1.2.5 Personalized Nutrition & Wellness
1.3 Global Personalized Medicine (PM) Solution Market by Application
1.3.1 Overview: Global Personalized Medicine (PM) Solution Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Oncology
1.3.3 Neurosciences
1.3.4 Immunology
1.3.5 Respiratory
1.3.6 Others
1.4 Global Personalized Medicine (PM) Solution Market Size & Forecast
1.5 Global Personalized Medicine (PM) Solution Market Size and Forecast by Region
1.5.1 Global Personalized Medicine (PM) Solution Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Personalized Medicine (PM) Solution Market Size by Region, (2017-2022)
1.5.3 North America Personalized Medicine (PM) Solution Market Size and Prospect (2017-2028)
1.5.4 Europe Personalized Medicine (PM) Solution Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Personalized Medicine (PM) Solution Market Size and Prospect (2017-2028)
1.5.6 South America Personalized Medicine (PM) Solution Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Personalized Medicine (PM) Solution Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Personalized Medicine (PM) Solution Market Drivers
1.6.2 Personalized Medicine (PM) Solution Market Restraints
1.6.3 Personalized Medicine (PM) Solution Trends Analysis
2 COMPANY PROFILES
2.1 2bPrecise
2.1.1 2bPrecise Details
2.1.2 2bPrecise Major Business
2.1.3 2bPrecise Personalized Medicine (PM) Solution Product and Solutions
2.1.4 2bPrecise Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 2bPrecise Recent Developments and Future Plans
2.2 OneOme
2.2.1 OneOme Details
2.2.2 OneOme Major Business
2.2.3 OneOme Personalized Medicine (PM) Solution Product and Solutions
2.2.4 OneOme Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 OneOme Recent Developments and Future Plans
2.3 TIGAR Health- IR2Dx
2.3.1 TIGAR Health- IR2Dx Details
2.3.2 TIGAR Health- IR2Dx Major Business
2.3.3 TIGAR Health- IR2Dx Personalized Medicine (PM) Solution Product and Solutions
2.3.4 TIGAR Health- IR2Dx Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 TIGAR Health- IR2Dx Recent Developments and Future Plans
2.4 Kailos Genetics
2.4.1 Kailos Genetics Details
2.4.2 Kailos Genetics Major Business
2.4.3 Kailos Genetics Personalized Medicine (PM) Solution Product and Solutions
2.4.4 Kailos Genetics Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Kailos Genetics Recent Developments and Future Plans
2.5 Syapse Inc
2.5.1 Syapse Inc Details
2.5.2 Syapse Inc Major Business
2.5.3 Syapse Inc Personalized Medicine (PM) Solution Product and Solutions
2.5.4 Syapse Inc Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Syapse Inc Recent Developments and Future Plans
2.6 Karius
2.6.1 Karius Details
2.6.2 Karius Major Business
2.6.3 Karius Personalized Medicine (PM) Solution Product and Solutions
2.6.4 Karius Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Karius Recent Developments and Future Plans
2.7 Astarte Medical
2.7.1 Astarte Medical Details
2.7.2 Astarte Medical Major Business
2.7.3 Astarte Medical Personalized Medicine (PM) Solution Product and Solutions
2.7.4 Astarte Medical Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Astarte Medical Recent Developments and Future Plans
2.8 Fabric Genomics, INC.
2.8.1 Fabric Genomics, INC. Details
2.8.2 Fabric Genomics, INC. Major Business
2.8.3 Fabric Genomics, INC. Personalized Medicine (PM) Solution Product and Solutions
2.8.4 Fabric Genomics, INC. Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Fabric Genomics, INC. Recent Developments and Future Plans
2.9 Orion Health
2.9.1 Orion Health Details
2.9.2 Orion Health Major Business
2.9.3 Orion Health Personalized Medicine (PM) Solution Product and Solutions
2.9.4 Orion Health Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Orion Health Recent Developments and Future Plans
2.10 2B Precise
2.10.1 2B Precise Details
2.10.2 2B Precise Major Business
2.10.3 2B Precise Personalized Medicine (PM) Solution Product and Solutions
2.10.4 2B Precise Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 2B Precise Recent Developments and Future Plans
2.11 Fabric Genomics
2.11.1 Fabric Genomics Details
2.11.2 Fabric Genomics Major Business
2.11.3 Fabric Genomics Personalized Medicine (PM) Solution Product and Solutions
2.11.4 Fabric Genomics Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Fabric Genomics Recent Developments and Future Plans
2.12 Pfizer
2.12.1 Pfizer Details
2.12.2 Pfizer Major Business
2.12.3 Pfizer Personalized Medicine (PM) Solution Product and Solutions
2.12.4 Pfizer Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Pfizer Recent Developments and Future Plans
2.13 Gene
2.13.1 Gene 42 Details
2.13.2 Gene 42 Major Business
2.13.3 Gene 42 Personalized Medicine (PM) Solution Product and Solutions
2.13.4 Gene 42 Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Gene 42 Recent Developments and Future Plans
2.14 IBM Watson Health
2.14.1 IBM Watson Health Details
2.14.2 IBM Watson Health Major Business
2.14.3 IBM Watson Health Personalized Medicine (PM) Solution Product and Solutions
2.14.4 IBM Watson Health Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 IBM Watson Health Recent Developments and Future Plans
2.15 Philips Healthcare
2.15.1 Philips Healthcare Details
2.15.2 Philips Healthcare Major Business
2.15.3 Philips Healthcare Personalized Medicine (PM) Solution Product and Solutions
2.15.4 Philips Healthcare Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Philips Healthcare Recent Developments and Future Plans
2.16 Medtronic
2.16.1 Medtronic Details
2.16.2 Medtronic Major Business
2.16.3 Medtronic Personalized Medicine (PM) Solution Product and Solutions
2.16.4 Medtronic Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 Medtronic Recent Developments and Future Plans
2.17 Nanthealth
2.17.1 Nanthealth Details
2.17.2 Nanthealth Major Business
2.17.3 Nanthealth Personalized Medicine (PM) Solution Product and Solutions
2.17.4 Nanthealth Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17.5 Nanthealth Recent Developments and Future Plans
2.18 Navican
2.18.1 Navican Details
2.18.2 Navican Major Business
2.18.3 Navican Personalized Medicine (PM) Solution Product and Solutions
2.18.4 Navican Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18.5 Navican Recent Developments and Future Plans
2.19 N-of-One
2.19.1 N-of-One Details
2.19.2 N-of-One Major Business
2.19.3 N-of-One Personalized Medicine (PM) Solution Product and Solutions
2.19.4 N-of-One Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19.5 N-of-One Recent Developments and Future Plans
2.20 PierianDx
2.20.1 PierianDx Details
2.20.2 PierianDx Major Business
2.20.3 PierianDx Personalized Medicine (PM) Solution Product and Solutions
2.20.4 PierianDx Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20.5 PierianDx Recent Developments and Future Plans
2.21 Sunquest Information System
2.21.1 Sunquest Information System Details
2.21.2 Sunquest Information System Major Business
2.21.3 Sunquest Information System Personalized Medicine (PM) Solution Product and Solutions
2.21.4 Sunquest Information System Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.21.5 Sunquest Information System Recent Developments and Future Plans
2.22 Tempus
2.22.1 Tempus Details
2.22.2 Tempus Major Business
2.22.3 Tempus Personalized Medicine (PM) Solution Product and Solutions
2.22.4 Tempus Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.22.5 Tempus Recent Developments and Future Plans
2.23 Novartis
2.23.1 Novartis Details
2.23.2 Novartis Major Business
2.23.3 Novartis Personalized Medicine (PM) Solution Product and Solutions
2.23.4 Novartis Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.23.5 Novartis Recent Developments and Future Plans
2.24 Translational Software
2.24.1 Translational Software Details
2.24.2 Translational Software Major Business
2.24.3 Translational Software Personalized Medicine (PM) Solution Product and Solutions
2.24.4 Translational Software Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.24.5 Translational Software Recent Developments and Future Plans
2.25 Biocrates Life Sciences AG
2.25.1 Biocrates Life Sciences AG Details
2.25.2 Biocrates Life Sciences AG Major Business
2.25.3 Biocrates Life Sciences AG Personalized Medicine (PM) Solution Product and Solutions
2.25.4 Biocrates Life Sciences AG Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.25.5 Biocrates Life Sciences AG Recent Developments and Future Plans
2.26 Nanostring Technologies
2.26.1 Nanostring Technologies Details
2.26.2 Nanostring Technologies Major Business
2.26.3 Nanostring Technologies Personalized Medicine (PM) Solution Product and Solutions
2.26.4 Nanostring Technologies Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.26.5 Nanostring Technologies Recent Developments and Future Plans
2.27 Thermo Fisher Scientific
2.27.1 Thermo Fisher Scientific Details
2.27.2 Thermo Fisher Scientific Major Business
2.27.3 Thermo Fisher Scientific Personalized Medicine (PM) Solution Product and Solutions
2.27.4 Thermo Fisher Scientific Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.27.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.28 Quest Diagnostics Incorporated
2.28.1 Quest Diagnostics Incorporated Details
2.28.2 Quest Diagnostics Incorporated Major Business
2.28.3 Quest Diagnostics Incorporated Personalized Medicine (PM) Solution Product and Solutions
2.28.4 Quest Diagnostics Incorporated Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.28.5 Quest Diagnostics Incorporated Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Personalized Medicine (PM) Solution Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Personalized Medicine (PM) Solution Players Market Share in 2021
3.2.2 Top 10 Personalized Medicine (PM) Solution Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Personalized Medicine (PM) Solution Players Head Office, Products and Services Provided
3.4 Personalized Medicine (PM) Solution Mergers & Acquisitions
3.5 Personalized Medicine (PM) Solution New Entrants and Expansion Plans
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Personalized Medicine (PM) Solution Revenue and Market Share by Type (2017-2022)
4.2 Global Personalized Medicine (PM) Solution Market Forecast by Type (2023-2028)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Personalized Medicine (PM) Solution Revenue Market Share by Application (2017-2022)
5.2 Global Personalized Medicine (PM) Solution Market Forecast by Application (2023-2028)
6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
6.1 North America Personalized Medicine (PM) Solution Revenue by Type (2017-2028)
6.2 North America Personalized Medicine (PM) Solution Revenue by Application (2017-2028)
6.3 North America Personalized Medicine (PM) Solution Market Size by Country
6.3.1 North America Personalized Medicine (PM) Solution Revenue by Country (2017-2028)
6.3.2 United States Personalized Medicine (PM) Solution Market Size and Forecast (2017-2028)
6.3.3 Canada Personalized Medicine (PM) Solution Market Size and Forecast (2017-2028)
6.3.4 Mexico Personalized Medicine (PM) Solution Market Size and Forecast (2017-2028)
7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 Europe Personalized Medicine (PM) Solution Revenue by Type (2017-2028)
7.2 Europe Personalized Medicine (PM) Solution Revenue by Application (2017-2028)
7.3 Europe Personalized Medicine (PM) Solution Market Size by Country
7.3.1 Europe Personalized Medicine (PM) Solution Revenue by Country (2017-2028)
7.3.2 Germany Personalized Medicine (PM) Solution Market Size and Forecast (2017-2028)
7.3.3 France Personalized Medicine (PM) Solution Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Personalized Medicine (PM) Solution Market Size and Forecast (2017-2028)
7.3.5 Russia Personalized Medicine (PM) Solution Market Size and Forecast (2017-2028)
7.3.6 Italy Personalized Medicine (PM) Solution Market Size and Forecast (2017-2028)
8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
8.1 Asia-Pacific Personalized Medicine (PM) Solution Revenue by Type (2017-2028)
8.2 Asia-Pacific Personalized Medicine (PM) Solution Revenue by Application (2017-2028)
8.3 Asia-Pacific Personalized Medicine (PM) Solution Market Size by Region
8.3.1 Asia-Pacific Personalized Medicine (PM) Solution Revenue by Region (2017-2028)
8.3.2 China Personalized Medicine (PM) Solution Market Size and Forecast (2017-2028)
8.3.3 Japan Personalized Medicine (PM) Solution Market Size and Forecast (2017-2028)
8.3.4 South Korea Personalized Medicine (PM) Solution Market Size and Forecast (2017-2028)
8.3.5 India Personalized Medicine (PM) Solution Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Personalized Medicine (PM) Solution Market Size and Forecast (2017-2028)
8.3.7 Australia Personalized Medicine (PM) Solution Market Size and Forecast (2017-2028)
9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
9.1 South America Personalized Medicine (PM) Solution Revenue by Type (2017-2028)
9.2 South America Personalized Medicine (PM) Solution Revenue by Application (2017-2028)
9.3 South America Personalized Medicine (PM) Solution Market Size by Country
9.3.1 South America Personalized Medicine (PM) Solution Revenue by Country (2017-2028)
9.3.2 Brazil Personalized Medicine (PM) Solution Market Size and Forecast (2017-2028)
9.3.3 Argentina Personalized Medicine (PM) Solution Market Size and Forecast (2017-2028)
10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
10.1 Middle East & Africa Personalized Medicine (PM) Solution Revenue by Type (2017-2028)
10.2 Middle East & Africa Personalized Medicine (PM) Solution Revenue by Application (2017-2028)
10.3 Middle East & Africa Personalized Medicine (PM) Solution Market Size by Country
10.3.1 Middle East & Africa Personalized Medicine (PM) Solution Revenue by Country (2017-2028)
10.3.2 Turkey Personalized Medicine (PM) Solution Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Personalized Medicine (PM) Solution Market Size and Forecast (2017-2028)
10.3.4 UAE Personalized Medicine (PM) Solution Market Size and Forecast (2017-2028)
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. Global Personalized Medicine (PM) Solution Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Personalized Medicine (PM) Solution Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Personalized Medicine (PM) Solution Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Personalized Medicine (PM) Solution Revenue (USD Million) by Region (2017-2022)
Table 5. Global Personalized Medicine (PM) Solution Revenue Market Share by Region (2023-2028)
Table 6. 2bPrecise Corporate Information, Head Office, and Major Competitors
Table 7. 2bPrecise Major Business
Table 8. 2bPrecise Personalized Medicine (PM) Solution Product and Solutions
Table 9. 2bPrecise Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. OneOme Corporate Information, Head Office, and Major Competitors
Table 11. OneOme Major Business
Table 12. OneOme Personalized Medicine (PM) Solution Product and Solutions
Table 13. OneOme Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. TIGAR Health- IR2Dx Corporate Information, Head Office, and Major Competitors
Table 15. TIGAR Health- IR2Dx Major Business
Table 16. TIGAR Health- IR2Dx Personalized Medicine (PM) Solution Product and Solutions
Table 17. TIGAR Health- IR2Dx Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Kailos Genetics Corporate Information, Head Office, and Major Competitors
Table 19. Kailos Genetics Major Business
Table 20. Kailos Genetics Personalized Medicine (PM) Solution Product and Solutions
Table 21. Kailos Genetics Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Syapse Inc Corporate Information, Head Office, and Major Competitors
Table 23. Syapse Inc Major Business
Table 24. Syapse Inc Personalized Medicine (PM) Solution Product and Solutions
Table 25. Syapse Inc Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Karius Corporate Information, Head Office, and Major Competitors
Table 27. Karius Major Business
Table 28. Karius Personalized Medicine (PM) Solution Product and Solutions
Table 29. Karius Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Astarte Medical Corporate Information, Head Office, and Major Competitors
Table 31. Astarte Medical Major Business
Table 32. Astarte Medical Personalized Medicine (PM) Solution Product and Solutions
Table 33. Astarte Medical Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Fabric Genomics, INC. Corporate Information, Head Office, and Major Competitors
Table 35. Fabric Genomics, INC. Major Business
Table 36. Fabric Genomics, INC. Personalized Medicine (PM) Solution Product and Solutions
Table 37. Fabric Genomics, INC. Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Orion Health Corporate Information, Head Office, and Major Competitors
Table 39. Orion Health Major Business
Table 40. Orion Health Personalized Medicine (PM) Solution Product and Solutions
Table 41. Orion Health Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. 2B Precise Corporate Information, Head Office, and Major Competitors
Table 43. 2B Precise Major Business
Table 44. 2B Precise Personalized Medicine (PM) Solution Product and Solutions
Table 45. 2B Precise Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Fabric Genomics Corporate Information, Head Office, and Major Competitors
Table 47. Fabric Genomics Major Business
Table 48. Fabric Genomics Personalized Medicine (PM) Solution Product and Solutions
Table 49. Fabric Genomics Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Pfizer Corporate Information, Head Office, and Major Competitors
Table 51. Pfizer Major Business
Table 52. Pfizer Personalized Medicine (PM) Solution Product and Solutions
Table 53. Pfizer Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Gene 42 Corporate Information, Head Office, and Major Competitors
Table 55. Gene 42 Major Business
Table 56. Gene 42 Personalized Medicine (PM) Solution Product and Solutions
Table 57. Gene 42 Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. IBM Watson Health Corporate Information, Head Office, and Major Competitors
Table 59. IBM Watson Health Major Business
Table 60. IBM Watson Health Personalized Medicine (PM) Solution Product and Solutions
Table 61. IBM Watson Health Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Philips Healthcare Corporate Information, Head Office, and Major Competitors
Table 63. Philips Healthcare Major Business
Table 64. Philips Healthcare Personalized Medicine (PM) Solution Product and Solutions
Table 65. Philips Healthcare Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Medtronic Corporate Information, Head Office, and Major Competitors
Table 67. Medtronic Major Business
Table 68. Medtronic Personalized Medicine (PM) Solution Product and Solutions
Table 69. Medtronic Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Nanthealth Corporate Information, Head Office, and Major Competitors
Table 71. Nanthealth Major Business
Table 72. Nanthealth Personalized Medicine (PM) Solution Product and Solutions
Table 73. Nanthealth Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 74. Navican Corporate Information, Head Office, and Major Competitors
Table 75. Navican Major Business
Table 76. Navican Personalized Medicine (PM) Solution Product and Solutions
Table 77. Navican Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 78. N-of-One Corporate Information, Head Office, and Major Competitors
Table 79. N-of-One Major Business
Table 80. N-of-One Personalized Medicine (PM) Solution Product and Solutions
Table 81. N-of-One Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 82. PierianDx Corporate Information, Head Office, and Major Competitors
Table 83. PierianDx Major Business
Table 84. PierianDx Personalized Medicine (PM) Solution Product and Solutions
Table 85. PierianDx Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 86. Sunquest Information System Corporate Information, Head Office, and Major Competitors
Table 87. Sunquest Information System Major Business
Table 88. Sunquest Information System Personalized Medicine (PM) Solution Product and Solutions
Table 89. Sunquest Information System Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 90. Tempus Corporate Information, Head Office, and Major Competitors
Table 91. Tempus Major Business
Table 92. Tempus Personalized Medicine (PM) Solution Product and Solutions
Table 93. Tempus Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 94. Novartis Corporate Information, Head Office, and Major Competitors
Table 95. Novartis Major Business
Table 96. Novartis Personalized Medicine (PM) Solution Product and Solutions
Table 97. Novartis Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 98. Translational Software Corporate Information, Head Office, and Major Competitors
Table 99. Translational Software Major Business
Table 100. Translational Software Personalized Medicine (PM) Solution Product and Solutions
Table 101. Translational Software Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 102. Biocrates Life Sciences AG Corporate Information, Head Office, and Major Competitors
Table 103. Biocrates Life Sciences AG Major Business
Table 104. Biocrates Life Sciences AG Personalized Medicine (PM) Solution Product and Solutions
Table 105. Biocrates Life Sciences AG Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 106. Nanostring Technologies Corporate Information, Head Office, and Major Competitors
Table 107. Nanostring Technologies Major Business
Table 108. Nanostring Technologies Personalized Medicine (PM) Solution Product and Solutions
Table 109. Nanostring Technologies Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 110. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 111. Thermo Fisher Scientific Major Business
Table 112. Thermo Fisher Scientific Personalized Medicine (PM) Solution Product and Solutions
Table 113. Thermo Fisher Scientific Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 114. Quest Diagnostics Incorporated Corporate Information, Head Office, and Major Competitors
Table 115. Quest Diagnostics Incorporated Major Business
Table 116. Quest Diagnostics Incorporated Personalized Medicine (PM) Solution Product and Solutions
Table 117. Quest Diagnostics Incorporated Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 118. Global Personalized Medicine (PM) Solution Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 119. Global Personalized Medicine (PM) Solution Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 120. Breakdown of Personalized Medicine (PM) Solution by Company Type (Tier 1, Tier 2 and Tier 3)
Table 121. Personalized Medicine (PM) Solution Players Head Office, Products and Services Provided
Table 122. Personalized Medicine (PM) Solution Mergers & Acquisitions in the Past Five Years
Table 123. Personalized Medicine (PM) Solution New Entrants and Expansion Plans
Table 124. Global Personalized Medicine (PM) Solution Revenue (USD Million) by Type (2017-2022)
Table 125. Global Personalized Medicine (PM) Solution Revenue Share by Type (2017-2022)
Table 126. Global Personalized Medicine (PM) Solution Revenue Forecast by Type (2023-2028)
Table 127. Global Personalized Medicine (PM) Solution Revenue by Application (2017-2022)
Table 128. Global Personalized Medicine (PM) Solution Revenue Forecast by Application (2023-2028)
Table 129. North America Personalized Medicine (PM) Solution Revenue by Type (2017-2022) & (USD Million)
Table 130. North America Personalized Medicine (PM) Solution Revenue by Type (2023-2028) & (USD Million)
Table 131. North America Personalized Medicine (PM) Solution Revenue by Application (2017-2022) & (USD Million)
Table 132. North America Personalized Medicine (PM) Solution Revenue by Application (2023-2028) & (USD Million)
Table 133. North America Personalized Medicine (PM) Solution Revenue by Country (2017-2022) & (USD Million)
Table 134. North America Personalized Medicine (PM) Solution Revenue by Country (2023-2028) & (USD Million)
Table 135. Europe Personalized Medicine (PM) Solution Revenue by Type (2017-2022) & (USD Million)
Table 136. Europe Personalized Medicine (PM) Solution Revenue by Type (2023-2028) & (USD Million)
Table 137. Europe Personalized Medicine (PM) Solution Revenue by Application (2017-2022) & (USD Million)
Table 138. Europe Personalized Medicine (PM) Solution Revenue by Application (2023-2028) & (USD Million)
Table 139. Europe Personalized Medicine (PM) Solution Revenue by Country (2017-2022) & (USD Million)
Table 140. Europe Personalized Medicine (PM) Solution Revenue by Country (2023-2028) & (USD Million)
Table 141. Asia-Pacific Personalized Medicine (PM) Solution Revenue by Type (2017-2022) & (USD Million)
Table 142. Asia-Pacific Personalized Medicine (PM) Solution Revenue by Type (2023-2028) & (USD Million)
Table 143. Asia-Pacific Personalized Medicine (PM) Solution Revenue by Application (2017-2022) & (USD Million)
Table 144. Asia-Pacific Personalized Medicine (PM) Solution Revenue by Application (2023-2028) & (USD Million)
Table 145. Asia-Pacific Personalized Medicine (PM) Solution Revenue by Region (2017-2022) & (USD Million)
Table 146. Asia-Pacific Personalized Medicine (PM) Solution Revenue by Region (2023-2028) & (USD Million)
Table 147. South America Personalized Medicine (PM) Solution Revenue by Type (2017-2022) & (USD Million)
Table 148. South America Personalized Medicine (PM) Solution Revenue by Type (2023-2028) & (USD Million)
Table 149. South America Personalized Medicine (PM) Solution Revenue by Application (2017-2022) & (USD Million)
Table 150. South America Personalized Medicine (PM) Solution Revenue by Application (2023-2028) & (USD Million)
Table 151. South America Personalized Medicine (PM) Solution Revenue by Country (2017-2022) & (USD Million)
Table 152. South America Personalized Medicine (PM) Solution Revenue by Country (2023-2028) & (USD Million)
Table 153. Middle East & Africa Personalized Medicine (PM) Solution Revenue by Type (2017-2022) & (USD Million)
Table 154. Middle East & Africa Personalized Medicine (PM) Solution Revenue by Type (2023-2028) & (USD Million)
Table 155. Middle East & Africa Personalized Medicine (PM) Solution Revenue by Application (2017-2022) & (USD Million)
Table 156. Middle East & Africa Personalized Medicine (PM) Solution Revenue by Application (2023-2028) & (USD Million)
Table 157. Middle East & Africa Personalized Medicine (PM) Solution Revenue by Country (2017-2022) & (USD Million)
Table 158. Middle East & Africa Personalized Medicine (PM) Solution Revenue by Country (2023-2028) & (USD Million)
Table 1. Global Personalized Medicine (PM) Solution Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Personalized Medicine (PM) Solution Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Personalized Medicine (PM) Solution Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Personalized Medicine (PM) Solution Revenue (USD Million) by Region (2017-2022)
Table 5. Global Personalized Medicine (PM) Solution Revenue Market Share by Region (2023-2028)
Table 6. 2bPrecise Corporate Information, Head Office, and Major Competitors
Table 7. 2bPrecise Major Business
Table 8. 2bPrecise Personalized Medicine (PM) Solution Product and Solutions
Table 9. 2bPrecise Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. OneOme Corporate Information, Head Office, and Major Competitors
Table 11. OneOme Major Business
Table 12. OneOme Personalized Medicine (PM) Solution Product and Solutions
Table 13. OneOme Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. TIGAR Health- IR2Dx Corporate Information, Head Office, and Major Competitors
Table 15. TIGAR Health- IR2Dx Major Business
Table 16. TIGAR Health- IR2Dx Personalized Medicine (PM) Solution Product and Solutions
Table 17. TIGAR Health- IR2Dx Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Kailos Genetics Corporate Information, Head Office, and Major Competitors
Table 19. Kailos Genetics Major Business
Table 20. Kailos Genetics Personalized Medicine (PM) Solution Product and Solutions
Table 21. Kailos Genetics Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Syapse Inc Corporate Information, Head Office, and Major Competitors
Table 23. Syapse Inc Major Business
Table 24. Syapse Inc Personalized Medicine (PM) Solution Product and Solutions
Table 25. Syapse Inc Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Karius Corporate Information, Head Office, and Major Competitors
Table 27. Karius Major Business
Table 28. Karius Personalized Medicine (PM) Solution Product and Solutions
Table 29. Karius Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Astarte Medical Corporate Information, Head Office, and Major Competitors
Table 31. Astarte Medical Major Business
Table 32. Astarte Medical Personalized Medicine (PM) Solution Product and Solutions
Table 33. Astarte Medical Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Fabric Genomics, INC. Corporate Information, Head Office, and Major Competitors
Table 35. Fabric Genomics, INC. Major Business
Table 36. Fabric Genomics, INC. Personalized Medicine (PM) Solution Product and Solutions
Table 37. Fabric Genomics, INC. Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Orion Health Corporate Information, Head Office, and Major Competitors
Table 39. Orion Health Major Business
Table 40. Orion Health Personalized Medicine (PM) Solution Product and Solutions
Table 41. Orion Health Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. 2B Precise Corporate Information, Head Office, and Major Competitors
Table 43. 2B Precise Major Business
Table 44. 2B Precise Personalized Medicine (PM) Solution Product and Solutions
Table 45. 2B Precise Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Fabric Genomics Corporate Information, Head Office, and Major Competitors
Table 47. Fabric Genomics Major Business
Table 48. Fabric Genomics Personalized Medicine (PM) Solution Product and Solutions
Table 49. Fabric Genomics Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Pfizer Corporate Information, Head Office, and Major Competitors
Table 51. Pfizer Major Business
Table 52. Pfizer Personalized Medicine (PM) Solution Product and Solutions
Table 53. Pfizer Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Gene 42 Corporate Information, Head Office, and Major Competitors
Table 55. Gene 42 Major Business
Table 56. Gene 42 Personalized Medicine (PM) Solution Product and Solutions
Table 57. Gene 42 Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. IBM Watson Health Corporate Information, Head Office, and Major Competitors
Table 59. IBM Watson Health Major Business
Table 60. IBM Watson Health Personalized Medicine (PM) Solution Product and Solutions
Table 61. IBM Watson Health Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Philips Healthcare Corporate Information, Head Office, and Major Competitors
Table 63. Philips Healthcare Major Business
Table 64. Philips Healthcare Personalized Medicine (PM) Solution Product and Solutions
Table 65. Philips Healthcare Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Medtronic Corporate Information, Head Office, and Major Competitors
Table 67. Medtronic Major Business
Table 68. Medtronic Personalized Medicine (PM) Solution Product and Solutions
Table 69. Medtronic Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Nanthealth Corporate Information, Head Office, and Major Competitors
Table 71. Nanthealth Major Business
Table 72. Nanthealth Personalized Medicine (PM) Solution Product and Solutions
Table 73. Nanthealth Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 74. Navican Corporate Information, Head Office, and Major Competitors
Table 75. Navican Major Business
Table 76. Navican Personalized Medicine (PM) Solution Product and Solutions
Table 77. Navican Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 78. N-of-One Corporate Information, Head Office, and Major Competitors
Table 79. N-of-One Major Business
Table 80. N-of-One Personalized Medicine (PM) Solution Product and Solutions
Table 81. N-of-One Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 82. PierianDx Corporate Information, Head Office, and Major Competitors
Table 83. PierianDx Major Business
Table 84. PierianDx Personalized Medicine (PM) Solution Product and Solutions
Table 85. PierianDx Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 86. Sunquest Information System Corporate Information, Head Office, and Major Competitors
Table 87. Sunquest Information System Major Business
Table 88. Sunquest Information System Personalized Medicine (PM) Solution Product and Solutions
Table 89. Sunquest Information System Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 90. Tempus Corporate Information, Head Office, and Major Competitors
Table 91. Tempus Major Business
Table 92. Tempus Personalized Medicine (PM) Solution Product and Solutions
Table 93. Tempus Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 94. Novartis Corporate Information, Head Office, and Major Competitors
Table 95. Novartis Major Business
Table 96. Novartis Personalized Medicine (PM) Solution Product and Solutions
Table 97. Novartis Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 98. Translational Software Corporate Information, Head Office, and Major Competitors
Table 99. Translational Software Major Business
Table 100. Translational Software Personalized Medicine (PM) Solution Product and Solutions
Table 101. Translational Software Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 102. Biocrates Life Sciences AG Corporate Information, Head Office, and Major Competitors
Table 103. Biocrates Life Sciences AG Major Business
Table 104. Biocrates Life Sciences AG Personalized Medicine (PM) Solution Product and Solutions
Table 105. Biocrates Life Sciences AG Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 106. Nanostring Technologies Corporate Information, Head Office, and Major Competitors
Table 107. Nanostring Technologies Major Business
Table 108. Nanostring Technologies Personalized Medicine (PM) Solution Product and Solutions
Table 109. Nanostring Technologies Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 110. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 111. Thermo Fisher Scientific Major Business
Table 112. Thermo Fisher Scientific Personalized Medicine (PM) Solution Product and Solutions
Table 113. Thermo Fisher Scientific Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 114. Quest Diagnostics Incorporated Corporate Information, Head Office, and Major Competitors
Table 115. Quest Diagnostics Incorporated Major Business
Table 116. Quest Diagnostics Incorporated Personalized Medicine (PM) Solution Product and Solutions
Table 117. Quest Diagnostics Incorporated Personalized Medicine (PM) Solution Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 118. Global Personalized Medicine (PM) Solution Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 119. Global Personalized Medicine (PM) Solution Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 120. Breakdown of Personalized Medicine (PM) Solution by Company Type (Tier 1, Tier 2 and Tier 3)
Table 121. Personalized Medicine (PM) Solution Players Head Office, Products and Services Provided
Table 122. Personalized Medicine (PM) Solution Mergers & Acquisitions in the Past Five Years
Table 123. Personalized Medicine (PM) Solution New Entrants and Expansion Plans
Table 124. Global Personalized Medicine (PM) Solution Revenue (USD Million) by Type (2017-2022)
Table 125. Global Personalized Medicine (PM) Solution Revenue Share by Type (2017-2022)
Table 126. Global Personalized Medicine (PM) Solution Revenue Forecast by Type (2023-2028)
Table 127. Global Personalized Medicine (PM) Solution Revenue by Application (2017-2022)
Table 128. Global Personalized Medicine (PM) Solution Revenue Forecast by Application (2023-2028)
Table 129. North America Personalized Medicine (PM) Solution Revenue by Type (2017-2022) & (USD Million)
Table 130. North America Personalized Medicine (PM) Solution Revenue by Type (2023-2028) & (USD Million)
Table 131. North America Personalized Medicine (PM) Solution Revenue by Application (2017-2022) & (USD Million)
Table 132. North America Personalized Medicine (PM) Solution Revenue by Application (2023-2028) & (USD Million)
Table 133. North America Personalized Medicine (PM) Solution Revenue by Country (2017-2022) & (USD Million)
Table 134. North America Personalized Medicine (PM) Solution Revenue by Country (2023-2028) & (USD Million)
Table 135. Europe Personalized Medicine (PM) Solution Revenue by Type (2017-2022) & (USD Million)
Table 136. Europe Personalized Medicine (PM) Solution Revenue by Type (2023-2028) & (USD Million)
Table 137. Europe Personalized Medicine (PM) Solution Revenue by Application (2017-2022) & (USD Million)
Table 138. Europe Personalized Medicine (PM) Solution Revenue by Application (2023-2028) & (USD Million)
Table 139. Europe Personalized Medicine (PM) Solution Revenue by Country (2017-2022) & (USD Million)
Table 140. Europe Personalized Medicine (PM) Solution Revenue by Country (2023-2028) & (USD Million)
Table 141. Asia-Pacific Personalized Medicine (PM) Solution Revenue by Type (2017-2022) & (USD Million)
Table 142. Asia-Pacific Personalized Medicine (PM) Solution Revenue by Type (2023-2028) & (USD Million)
Table 143. Asia-Pacific Personalized Medicine (PM) Solution Revenue by Application (2017-2022) & (USD Million)
Table 144. Asia-Pacific Personalized Medicine (PM) Solution Revenue by Application (2023-2028) & (USD Million)
Table 145. Asia-Pacific Personalized Medicine (PM) Solution Revenue by Region (2017-2022) & (USD Million)
Table 146. Asia-Pacific Personalized Medicine (PM) Solution Revenue by Region (2023-2028) & (USD Million)
Table 147. South America Personalized Medicine (PM) Solution Revenue by Type (2017-2022) & (USD Million)
Table 148. South America Personalized Medicine (PM) Solution Revenue by Type (2023-2028) & (USD Million)
Table 149. South America Personalized Medicine (PM) Solution Revenue by Application (2017-2022) & (USD Million)
Table 150. South America Personalized Medicine (PM) Solution Revenue by Application (2023-2028) & (USD Million)
Table 151. South America Personalized Medicine (PM) Solution Revenue by Country (2017-2022) & (USD Million)
Table 152. South America Personalized Medicine (PM) Solution Revenue by Country (2023-2028) & (USD Million)
Table 153. Middle East & Africa Personalized Medicine (PM) Solution Revenue by Type (2017-2022) & (USD Million)
Table 154. Middle East & Africa Personalized Medicine (PM) Solution Revenue by Type (2023-2028) & (USD Million)
Table 155. Middle East & Africa Personalized Medicine (PM) Solution Revenue by Application (2017-2022) & (USD Million)
Table 156. Middle East & Africa Personalized Medicine (PM) Solution Revenue by Application (2023-2028) & (USD Million)
Table 157. Middle East & Africa Personalized Medicine (PM) Solution Revenue by Country (2017-2022) & (USD Million)
Table 158. Middle East & Africa Personalized Medicine (PM) Solution Revenue by Country (2023-2028) & (USD Million)
LIST OF FIGURES
Figure 1. Personalized Medicine (PM) Solution Picture
Figure 2. Global Personalized Medicine (PM) Solution Revenue Market Share by Type in 2021
Figure 3. Personalized Diagnostics
Figure 4. Personalized Therapies
Figure 5. Personalized Nutrition & Wellness
Figure 6. Personalized Medicine (PM) Solution Revenue Market Share by Application in 2021
Figure 7. Oncology Picture
Figure 8. Neurosciences Picture
Figure 9. Immunology Picture
Figure 10. Respiratory Picture
Figure 11. Others Picture
Figure 12. Global Personalized Medicine (PM) Solution Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 13. Global Personalized Medicine (PM) Solution Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Personalized Medicine (PM) Solution Revenue Market Share by Region (2017-2028)
Figure 15. Global Personalized Medicine (PM) Solution Revenue Market Share by Region in 2021
Figure 16. North America Personalized Medicine (PM) Solution Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Europe Personalized Medicine (PM) Solution Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Asia-Pacific Personalized Medicine (PM) Solution Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. South America Personalized Medicine (PM) Solution Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Middle East and Africa Personalized Medicine (PM) Solution Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Personalized Medicine (PM) Solution Market Drivers
Figure 22. Personalized Medicine (PM) Solution Market Restraints
Figure 23. Personalized Medicine (PM) Solution Market Trends
Figure 24. 2bPrecise Recent Developments and Future Plans
Figure 25. OneOme Recent Developments and Future Plans
Figure 26. TIGAR Health- IR2Dx Recent Developments and Future Plans
Figure 27. Kailos Genetics Recent Developments and Future Plans
Figure 28. Syapse Inc Recent Developments and Future Plans
Figure 29. Karius Recent Developments and Future Plans
Figure 30. Astarte Medical Recent Developments and Future Plans
Figure 31. Fabric Genomics, INC. Recent Developments and Future Plans
Figure 32. Orion Health Recent Developments and Future Plans
Figure 33. 2B Precise Recent Developments and Future Plans
Figure 34. Fabric Genomics Recent Developments and Future Plans
Figure 35. Pfizer Recent Developments and Future Plans
Figure 36. Gene 42 Recent Developments and Future Plans
Figure 37. IBM Watson Health Recent Developments and Future Plans
Figure 38. Philips Healthcare Recent Developments and Future Plans
Figure 39. Medtronic Recent Developments and Future Plans
Figure 40. Nanthealth Recent Developments and Future Plans
Figure 41. Navican Recent Developments and Future Plans
Figure 42. N-of-One Recent Developments and Future Plans
Figure 43. PierianDx Recent Developments and Future Plans
Figure 44. Sunquest Information System Recent Developments and Future Plans
Figure 45. Tempus Recent Developments and Future Plans
Figure 46. Novartis Recent Developments and Future Plans
Figure 47. Translational Software Recent Developments and Future Plans
Figure 48. Biocrates Life Sciences AG Recent Developments and Future Plans
Figure 49. Nanostring Technologies Recent Developments and Future Plans
Figure 50. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 51. Quest Diagnostics Incorporated Recent Developments and Future Plans
Figure 52. Global Personalized Medicine (PM) Solution Revenue Share by Players in 2021
Figure 53. Personalized Medicine (PM) Solution Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 54. Global Top 3 Players Personalized Medicine (PM) Solution Revenue Market Share in 2021
Figure 55. Global Top 10 Players Personalized Medicine (PM) Solution Revenue Market Share in 2021
Figure 56. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 57. Global Personalized Medicine (PM) Solution Revenue Share by Type in 2021
Figure 58. Global Personalized Medicine (PM) Solution Market Share Forecast by Type (2023-2028)
Figure 59. Global Personalized Medicine (PM) Solution Revenue Share by Application in 2021
Figure 60. Global Personalized Medicine (PM) Solution Market Share Forecast by Application (2023-2028)
Figure 61. North America Personalized Medicine (PM) Solution Sales Market Share by Type (2017-2028)
Figure 62. North America Personalized Medicine (PM) Solution Sales Market Share by Application (2017-2028)
Figure 63. North America Personalized Medicine (PM) Solution Revenue Market Share by Country (2017-2028)
Figure 64. United States Personalized Medicine (PM) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Canada Personalized Medicine (PM) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Mexico Personalized Medicine (PM) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Europe Personalized Medicine (PM) Solution Sales Market Share by Type (2017-2028)
Figure 68. Europe Personalized Medicine (PM) Solution Sales Market Share by Application (2017-2028)
Figure 69. Europe Personalized Medicine (PM) Solution Revenue Market Share by Country (2017-2028)
Figure 70. Germany Personalized Medicine (PM) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. France Personalized Medicine (PM) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. United Kingdom Personalized Medicine (PM) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Russia Personalized Medicine (PM) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Italy Personalized Medicine (PM) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Asia-Pacific Personalized Medicine (PM) Solution Sales Market Share by Type (2017-2028)
Figure 76. Asia-Pacific Personalized Medicine (PM) Solution Sales Market Share by Application (2017-2028)
Figure 77. Asia-Pacific Personalized Medicine (PM) Solution Revenue Market Share by Region (2017-2028)
Figure 78. China Personalized Medicine (PM) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Japan Personalized Medicine (PM) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. South Korea Personalized Medicine (PM) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. India Personalized Medicine (PM) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Southeast Asia Personalized Medicine (PM) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. Australia Personalized Medicine (PM) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 84. South America Personalized Medicine (PM) Solution Sales Market Share by Type (2017-2028)
Figure 85. South America Personalized Medicine (PM) Solution Sales Market Share by Application (2017-2028)
Figure 86. South America Personalized Medicine (PM) Solution Revenue Market Share by Country (2017-2028)
Figure 87. Brazil Personalized Medicine (PM) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 88. Argentina Personalized Medicine (PM) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 89. Middle East and Africa Personalized Medicine (PM) Solution Sales Market Share by Type (2017-2028)
Figure 90. Middle East and Africa Personalized Medicine (PM) Solution Sales Market Share by Application (2017-2028)
Figure 91. Middle East and Africa Personalized Medicine (PM) Solution Revenue Market Share by Country (2017-2028)
Figure 92. Turkey Personalized Medicine (PM) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 93. Saudi Arabia Personalized Medicine (PM) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 94. UAE Personalized Medicine (PM) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 95. Methodology
Figure 96. Research Process and Data Source
Figure 1. Personalized Medicine (PM) Solution Picture
Figure 2. Global Personalized Medicine (PM) Solution Revenue Market Share by Type in 2021
Figure 3. Personalized Diagnostics
Figure 4. Personalized Therapies
Figure 5. Personalized Nutrition & Wellness
Figure 6. Personalized Medicine (PM) Solution Revenue Market Share by Application in 2021
Figure 7. Oncology Picture
Figure 8. Neurosciences Picture
Figure 9. Immunology Picture
Figure 10. Respiratory Picture
Figure 11. Others Picture
Figure 12. Global Personalized Medicine (PM) Solution Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 13. Global Personalized Medicine (PM) Solution Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Personalized Medicine (PM) Solution Revenue Market Share by Region (2017-2028)
Figure 15. Global Personalized Medicine (PM) Solution Revenue Market Share by Region in 2021
Figure 16. North America Personalized Medicine (PM) Solution Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Europe Personalized Medicine (PM) Solution Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Asia-Pacific Personalized Medicine (PM) Solution Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. South America Personalized Medicine (PM) Solution Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Middle East and Africa Personalized Medicine (PM) Solution Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Personalized Medicine (PM) Solution Market Drivers
Figure 22. Personalized Medicine (PM) Solution Market Restraints
Figure 23. Personalized Medicine (PM) Solution Market Trends
Figure 24. 2bPrecise Recent Developments and Future Plans
Figure 25. OneOme Recent Developments and Future Plans
Figure 26. TIGAR Health- IR2Dx Recent Developments and Future Plans
Figure 27. Kailos Genetics Recent Developments and Future Plans
Figure 28. Syapse Inc Recent Developments and Future Plans
Figure 29. Karius Recent Developments and Future Plans
Figure 30. Astarte Medical Recent Developments and Future Plans
Figure 31. Fabric Genomics, INC. Recent Developments and Future Plans
Figure 32. Orion Health Recent Developments and Future Plans
Figure 33. 2B Precise Recent Developments and Future Plans
Figure 34. Fabric Genomics Recent Developments and Future Plans
Figure 35. Pfizer Recent Developments and Future Plans
Figure 36. Gene 42 Recent Developments and Future Plans
Figure 37. IBM Watson Health Recent Developments and Future Plans
Figure 38. Philips Healthcare Recent Developments and Future Plans
Figure 39. Medtronic Recent Developments and Future Plans
Figure 40. Nanthealth Recent Developments and Future Plans
Figure 41. Navican Recent Developments and Future Plans
Figure 42. N-of-One Recent Developments and Future Plans
Figure 43. PierianDx Recent Developments and Future Plans
Figure 44. Sunquest Information System Recent Developments and Future Plans
Figure 45. Tempus Recent Developments and Future Plans
Figure 46. Novartis Recent Developments and Future Plans
Figure 47. Translational Software Recent Developments and Future Plans
Figure 48. Biocrates Life Sciences AG Recent Developments and Future Plans
Figure 49. Nanostring Technologies Recent Developments and Future Plans
Figure 50. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 51. Quest Diagnostics Incorporated Recent Developments and Future Plans
Figure 52. Global Personalized Medicine (PM) Solution Revenue Share by Players in 2021
Figure 53. Personalized Medicine (PM) Solution Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 54. Global Top 3 Players Personalized Medicine (PM) Solution Revenue Market Share in 2021
Figure 55. Global Top 10 Players Personalized Medicine (PM) Solution Revenue Market Share in 2021
Figure 56. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 57. Global Personalized Medicine (PM) Solution Revenue Share by Type in 2021
Figure 58. Global Personalized Medicine (PM) Solution Market Share Forecast by Type (2023-2028)
Figure 59. Global Personalized Medicine (PM) Solution Revenue Share by Application in 2021
Figure 60. Global Personalized Medicine (PM) Solution Market Share Forecast by Application (2023-2028)
Figure 61. North America Personalized Medicine (PM) Solution Sales Market Share by Type (2017-2028)
Figure 62. North America Personalized Medicine (PM) Solution Sales Market Share by Application (2017-2028)
Figure 63. North America Personalized Medicine (PM) Solution Revenue Market Share by Country (2017-2028)
Figure 64. United States Personalized Medicine (PM) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Canada Personalized Medicine (PM) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Mexico Personalized Medicine (PM) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Europe Personalized Medicine (PM) Solution Sales Market Share by Type (2017-2028)
Figure 68. Europe Personalized Medicine (PM) Solution Sales Market Share by Application (2017-2028)
Figure 69. Europe Personalized Medicine (PM) Solution Revenue Market Share by Country (2017-2028)
Figure 70. Germany Personalized Medicine (PM) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. France Personalized Medicine (PM) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. United Kingdom Personalized Medicine (PM) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Russia Personalized Medicine (PM) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Italy Personalized Medicine (PM) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Asia-Pacific Personalized Medicine (PM) Solution Sales Market Share by Type (2017-2028)
Figure 76. Asia-Pacific Personalized Medicine (PM) Solution Sales Market Share by Application (2017-2028)
Figure 77. Asia-Pacific Personalized Medicine (PM) Solution Revenue Market Share by Region (2017-2028)
Figure 78. China Personalized Medicine (PM) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Japan Personalized Medicine (PM) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. South Korea Personalized Medicine (PM) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. India Personalized Medicine (PM) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Southeast Asia Personalized Medicine (PM) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. Australia Personalized Medicine (PM) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 84. South America Personalized Medicine (PM) Solution Sales Market Share by Type (2017-2028)
Figure 85. South America Personalized Medicine (PM) Solution Sales Market Share by Application (2017-2028)
Figure 86. South America Personalized Medicine (PM) Solution Revenue Market Share by Country (2017-2028)
Figure 87. Brazil Personalized Medicine (PM) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 88. Argentina Personalized Medicine (PM) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 89. Middle East and Africa Personalized Medicine (PM) Solution Sales Market Share by Type (2017-2028)
Figure 90. Middle East and Africa Personalized Medicine (PM) Solution Sales Market Share by Application (2017-2028)
Figure 91. Middle East and Africa Personalized Medicine (PM) Solution Revenue Market Share by Country (2017-2028)
Figure 92. Turkey Personalized Medicine (PM) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 93. Saudi Arabia Personalized Medicine (PM) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 94. UAE Personalized Medicine (PM) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 95. Methodology
Figure 96. Research Process and Data Source
